Reported covered position: Chief Counsel, Senate Judiciary Committee, Senator Lindsey Graham (2007-2012)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OURARING INC. via OURARING INC.
2026 · third_quarter · Q3
Issues related to tax benefits for health technology.
Issues related to regulation of health technology. Issues related to insurance coverage of health technology.
Source: Senate LDA
Issues related to enforcement of intellectual property rights.
Issues related to human performance technology.
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OURARING INC. via OURARING INC.
2026 · second_quarter · Q2
Issues related to regulation of health technology. Issues related to insurance coverage of health technology.
Issues related to human performance technology.
Issues related to tax benefits for health technology.
Issues related to enforcement of intellectual property rights.
Issues related to human performance technology.
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Secret Service
OURARING INC. via OURARING INC.
2026 · first_quarter · Q1
Issues related to human performance technology.
Issues related to regulation of health technology. Issues related to insurance coverage of health technology.
Issues related to tax benefits for health technology.
Issues related to enforcement of intellectual property rights.
Issues related to human performance technology.
Filing targets: Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE, Transportation Security Administration (TSA), U.S. Coast Guard (USCG), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. Secret Service
OURARING INC. via OURARING INC.
2025 · fourth_quarter · Q4
Issues related to regulation of health technology. Issues related to insurance coverage of health technology.
Issues related to enforcement of intellectual property rights.
Issues related to human performance technology; FY26 NDAA and FY26 Appropriations Act.
Issues related to tax benefits for health technology.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
OURARING INC. via OURARING INC.
2025 · third_quarter · Q3
Issues related to human performance technology; FY26 NDAA and FY26 Appropriations Act.
Issues related to tax benefits for health technology.
Issues related to regulation of health technology. Issues related to insurance coverage of health technology.
Issues related to enforcement of intellectual property rights.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
OURARING INC. via OURARING INC.
2025 · second_quarter · 2A
Issues related to tax benefits for health technology.
Issues related to regulation of health technology. Issues related to insurance coverage of health technology.
Issues related to enforcement of intellectual property rights.
OURARING INC. via OURARING INC.
2025 · second_quarter · RR
Issues related to regulation of health technology. Issues related to enforcement of intellectual property rights. Issues related to defense acquisition of human performance technology. Issues related to tax benefits and insurance coverage of health technology.
Issues related to regulation of health technology. Issues related to enforcement of intellectual property rights. Issues related to defense acquisition of human performance technology. Issues related to tax benefits and insurance coverage of health technology.
Issues related to regulation of health technology. Issues related to enforcement of intellectual property rights. Issues related to defense acquisition of human performance technology. Issues related to tax benefits and insurance coverage of health technology.
Issues related to human performance technology; FY26 NDAA and FY26 Appropriations Act.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to regulation of health technology. Issues related to enforcement of intellectual property rights. Issues related to defense acquisition of human performance technology. Issues related to tax benefits and insurance coverage of health technology.